StockData
Solid Biosciences Inc. logo

Solid Biosciences Inc. (SLDB) stock

SLDBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$6.35+0.12 (+1.93%)

Close on Nov 18, 2026Market cap $680.88MP/E –Yield –

Solid Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Solid Biosciences's market cap was $798.95M on Nov 11, 2026, against $422.90M a year earlier. Over the last 5 years it ranged from $40.53M to $1.01B, with a median of $191.43M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$798.95M+81.9%
2025Dec 31, 2025$439.26M+182.1%
2024Dec 31, 2024$155.72M+26.4%
2023Dec 29, 2023$123.18M+203.9%
2022Dec 30, 2022$40.53M-79.0%
2021Dec 31, 2021$193.01M-44.9%
2020Dec 31, 2020$350.02M+71.0%
2019Dec 31, 2019$204.69M-78.4%
2018Dec 31, 2018$949.54M–

More Solid Biosciences figures

See a number that looks wrong?